Jason B. Caron advises a full spectrum of healthcare and life sciences organizations on complex healthcare regulatory, reimbursement, and policy matters.
Mr. Caron leverages his clinical and government experiences, as well as nearly two decades of private practice, to help clients — ranging from early-stage innovators to established multifaceted national health systems — navigate the complex and evolving healthcare regulatory landscape, including:
- Payer participation, reimbursement, and program integrity matters, such as payment, coding, medical necessity and other coverage issues, surprise billing and other consumer protection issues, clinical documentation, and comparative research
- Federal and state fraud matters, including anti-kickback, Stark/self-referral, civil monetary penalty, exclusion, suspension, revocation, and false claim matters
- Advisory opinions; compliance reviews; internal investigations; self-disclosures; and government inquiries, audits, and investigations
- Healthcare licensure, accreditation, certification, quality, and risk management matters
He also regularly advises private equity, growth equity, and venture firms, as well as lenders, pension funds, and family offices that invest in or support the healthcare and life sciences communities. Mr. Caron helps clients efficiently manage healthcare regulatory risk by evaluating, developing, implementing, and enhancing corporate compliance and quality management programs. He routinely supports transactions, including complex joint ventures, strategic affiliations, medical practice support arrangements, leverage buy-outs, public company mergers, and recapitalizations.
Before joining Latham, Mr. Caron worked at another global law firm. He also previously worked for the US Department of Health and Human Services’ Office of General Counsel and as a critical care paramedic for an affiliate of a regional health system.